DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Clinical trials for DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Two-Drug combo aims to shrink tumors before surgery

Disease control Ongoing

This study is testing whether two immunotherapy drugs (iparomlimab and tuvonralimab) given before surgery can help shrink tumors in people with locally advanced rectal cancer that has specific genetic features. The main goal is to see if the treatment completely eliminates cancer…

Matched conditions: DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA

Get alerted when new DMMR/MSI-H-TYPE RECTAL ADENOCARCINOMA trials appear

Two-Drug combo aims to shrink tumors before surgery